
Glimistar PM 1mg/500mg/15mg Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimistar PM 1mg/500mg/15mg Tablet
Glimepiride-Metformin-Pioglitazone 1mg/500mg/15mg tablets offer a multi-component approach to managing elevated blood glucose. This formulation, used in conjunction with diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Adhere strictly to your physician's prescribed dosage and frequency. Ingestion with food minimizes gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double a dose; exceeding the recommended amount can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals increases the hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating therapy, disclose any existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function assessment will precede treatment commencement. Limit alcohol consumption to mitigate potential side effects.
Uses of Glimistar PM 1mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glimistar PM 1mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Glimistar PM 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.
Common Side effects of Glimistar PM 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimistar PM 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimistar PM 1mg/500mg/15mg tablets should be administered with food.
How Glimistar PM 1mg/500mg/15mg Tablet works:
Glimistar PM, a 1mg/500mg/15mg tablet, combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-action approach improves blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimistar PM 1mg/500mg/15mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glimistar PM 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Glimistar PM 1mg/500mg/15mg tablets are likely incompatible. Preliminary human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimistar PM 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use the 1mg/500mg/15mg Glimistar PM tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimistar PM 1mg/500mg/15mg Tablet :
Should you forget a Glimistar PM 1mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimistar PM 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
